Literature DB >> 22891271

Monoclonal antibody-based therapies: a new dawn in the treatment of acute lymphoblastic leukemia.

Hagop Kantarjian1, Deborah Thomas, Alan S Wayne, Susan O'Brien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22891271      PMCID： PMC3478578          DOI： 10.1200/JCO.2012.41.6768

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  61 in total

Review 1.  Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL).

Authors:  N Gökbuget; D Hoelzer; R Arnold; A Böhme; C R Bartram; M Freund; A Ganser; M Kneba; W Langer; T Lipp; W D Ludwig; G Maschmeyer; H Rieder; E Thiel; A Weiss; D Messerer
Journal:  Hematol Oncol Clin North Am       Date:  2000-12       Impact factor: 3.722

Review 2.  Ofatumumab, a novel anti-CD20 monoclonal antibody for the treatment of B-cell malignancies.

Authors:  Bruce D Cheson
Journal:  J Clin Oncol       Date:  2010-05-10       Impact factor: 44.544

3.  Surface antigens analysis reveals significant expression of candidate targets for immunotherapy in adult acute lymphoid leukemia.

Authors:  Pier Paolo Piccaluga; Mario Arpinati; Anna Candoni; Claudio Laterza; Stefania Paolini; Anna Gazzola; Elena Sabattini; Giuseppe Visani; Stefano A Pileri
Journal:  Leuk Lymphoma       Date:  2010-11-15

4.  Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases.

Authors:  Sara Raponi; Maria Stefania De Propris; Stefania Intoppa; Maria Laura Milani; Antonella Vitale; Loredana Elia; Omar Perbellini; Giovanni Pizzolo; Robin Foá; Anna Guarini
Journal:  Leuk Lymphoma       Date:  2011-02-24

5.  Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia.

Authors:  Francis Mussai; Dario Campana; Deepa Bhojwani; Maryalice Stetler-Stevenson; Seth M Steinberg; Alan S Wayne; Ira Pastan
Journal:  Br J Haematol       Date:  2010-06-07       Impact factor: 6.998

6.  Induction of long-term remission of a relapsed childhood B-acute lymphoblastic leukemia with rituximab chimeric anti-CD20 monoclonal antibody and autologous stem cell transplantation.

Authors:  Selim Corbacioglu; Stefan Eber; Tayfun Gungor; Jorg Hummerjohann; Felix Niggli
Journal:  J Pediatr Hematol Oncol       Date:  2003-04       Impact factor: 1.289

7.  Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study.

Authors:  Michael J Keating; Ian Flinn; Vinay Jain; Jacques-Louis Binet; Peter Hillmen; John Byrd; Maher Albitar; Lee Brettman; Pedro Santabarbara; Bret Wacker; Kanti R Rai
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

8.  Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995.

Authors:  P S Gaynon; M E Trigg; N A Heerema; M G Sensel; H N Sather; G D Hammond; W A Bleyer
Journal:  Leukemia       Date:  2000-12       Impact factor: 11.528

9.  Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study.

Authors:  Hagop Kantarjian; Deborah Thomas; Jeffrey Jorgensen; Elias Jabbour; Partow Kebriaei; Michael Rytting; Sergernne York; Farhad Ravandi; Monica Kwari; Stefan Faderl; Mary Beth Rios; Jorge Cortes; Luis Fayad; Robert Tarnai; Sa A Wang; Richard Champlin; Anjali Advani; Susan O'Brien
Journal:  Lancet Oncol       Date:  2012-02-21       Impact factor: 41.316

10.  Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.

Authors:  Kirk R Schultz; W Paul Bowman; Alexander Aledo; William B Slayton; Harland Sather; Meenakshi Devidas; Chenguang Wang; Stella M Davies; Paul S Gaynon; Michael Trigg; Robert Rutledge; Laura Burden; Dean Jorstad; Andrew Carroll; Nyla A Heerema; Naomi Winick; Michael J Borowitz; Stephen P Hunger; William L Carroll; Bruce Camitta
Journal:  J Clin Oncol       Date:  2009-10-05       Impact factor: 44.544
View more
  33 in total

Review 1.  A 50-year journey to cure childhood acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui; William E Evans
Journal:  Semin Hematol       Date:  2013-07       Impact factor: 3.851

2.  Declining childhood and adolescent cancer mortality.

Authors:  Malcolm A Smith; Sean F Altekruse; Peter C Adamson; Gregory H Reaman; Nita L Seibel
Journal:  Cancer       Date:  2014-05-22       Impact factor: 6.860

3.  Personalized medicine in adult acute lymphoblastic leukemia.

Authors:  Dieter Hoelzer
Journal:  Haematologica       Date:  2015-07       Impact factor: 9.941

4.  Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.

Authors:  Hagop Kantarjian; Anthony Stein; Nicola Gökbuget; Adele K Fielding; Andre C Schuh; Josep-Maria Ribera; Andrew Wei; Hervé Dombret; Robin Foà; Renato Bassan; Önder Arslan; Miguel A Sanz; Julie Bergeron; Fatih Demirkan; Ewa Lech-Maranda; Alessandro Rambaldi; Xavier Thomas; Heinz-August Horst; Monika Brüggemann; Wolfram Klapper; Brent L Wood; Alex Fleishman; Dirk Nagorsen; Christopher Holland; Zachary Zimmerman; Max S Topp
Journal:  N Engl J Med       Date:  2017-03-02       Impact factor: 91.245

Review 5.  Treatment of older patients with acute lymphoblastic leukemia.

Authors:  Nicola Gökbuget
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

6.  Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia.

Authors:  Waleed Haso; Daniel W Lee; Nirali N Shah; Maryalice Stetler-Stevenson; Constance M Yuan; Ira H Pastan; Dimiter S Dimitrov; Richard A Morgan; David J FitzGerald; David M Barrett; Alan S Wayne; Crystal L Mackall; Rimas J Orentas
Journal:  Blood       Date:  2012-12-14       Impact factor: 22.113

7.  A simple, clinically relevant therapeutic vaccine shows long-term protection in an aggressive, delayed-treatment B lymphoma model.

Authors:  Pallab Pradhan; Jardin Leleux; Jiaying Liu; Krishnendu Roy
Journal:  JCI Insight       Date:  2017-11-16

Review 8.  Novel therapeutic strategies in adult acute lymphoblastic leukemia--a focus on emerging monoclonal antibodies.

Authors:  Naval Daver; Susan O'Brien
Journal:  Curr Hematol Malig Rep       Date:  2013-06       Impact factor: 3.952

Review 9.  The myth of the second remission of acute leukemia in the adult.

Authors:  Stephen J Forman; Jacob M Rowe
Journal:  Blood       Date:  2012-12-14       Impact factor: 22.113

10.  Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia.

Authors:  Farhad Ravandi; Jeffrey L Jorgensen; Susan M O'Brien; Elias Jabbour; Deborah A Thomas; Gautam Borthakur; Rebecca Garris; Xuelin Huang; Guillermo Garcia-Manero; Jan A Burger; Alessandra Ferrajoli; William Wierda; Tapan Kadia; Nitin Jain; Sa A Wang; Sergei Konoplev; Partow Kebriaei; Richard E Champlin; Deborah McCue; Zeev Estrov; Jorge E Cortes; Hagop M Kantarjian
Journal:  Br J Haematol       Date:  2015-10-22       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.